BioLineRx Ltd. to Report Third Quarter 2012 Results on November 14, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that it will release its unaudited financial results for the quarter ended September 30, 2012 on Wednesday, November 14, 2012, before the U.S. markets open. The Company will host a conference call on Wednesday, November 14 at 9:00 a.m. EST featuring remarks by Kinneret Savitsky, Ph.D., CEO of BioLineRx, and Philip Serlin, Chief Financial and Operating Officer of BioLineRx. The conference call will be available via webcast and can be accessed through the Investor Relations section of BioLineRx’s website, www.biolinerx.com, and www.kcsa.com. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast. To dial into the conference call, please dial 1-888-407-2553 from the U.S. or +972-3-918-0610 internationally.